MAPT yields 1000000.00% · PFE yields 6.20%● Live data
📍 MAPT pulled ahead of the other in Year 1
Combined, MAPT + PFE cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of MAPT + PFE for your $10,000?
Maptelligent, Inc. provides cloud based geographic platform. Its geographic platform integrates disparate data from sensors, cameras, alarms, and access control and accountability systems to create actionable intelligence on an intuitive map interface, as well as provides access information relevant to structures and sites that enhances situational awareness and emergency response while en route and upon arrival at the incident scene to mitigate additional loss of life and property of incidents occurring within buildings when shared with first responders. The company also provides a suite of maps and apps, which offers customers the ability to maintain and manage data in a mobile environment for public safety to create incident pre-plans associated with the building floor plan, as well as for building engineers to manage maintenance schedules for critical elements of a building, such as alarm panels, pull stations, extinguishers, and other assets, which need regular attention. In addition, it offers professional services (ProServ) to build high fidelity floor plans, safety assessments, and system integration services; and a cloud content management solution to store and manage data associated with the security solutions. The company serves organizations and entities, who are often at risk from threats and emergency incidents, such as schools, universities, hospitals, shopping malls, sporting events, commercial enterprises, and ports. Maptelligent, Inc. is based in Henderson, Nevada.
Full MAPT Calculator →Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under the Ibrance, Xtandi, Sutent, Inlyta, Retacrit, Lorbrena, and Braftovi brands; and sterile injectable and anti-infective medicines, and oral COVID-19 treatment under the Sulperazon, Medrol, Zavicefta, Zithromax, Vfend, Panzyga, and Paxlovid brands. The company also provides medicines and vaccines in various therapeutic areas, such as pneumococcal disease, meningococcal disease, tick-borne encephalitis, and COVID-19 under the Comirnaty/BNT162b2, Nimenrix, FSME/IMMUN-TicoVac, Trumenba, and the Prevnar family brands; biosimilars for chronic immune and inflammatory diseases under the Xeljanz, Enbrel, Inflectra, Eucrisa/Staquis, and Cibinqo brands; and amyloidosis, hemophilia, and endocrine diseases under the Vyndaqel/Vyndamax, BeneFIX, and Genotropin brands. In addition, the company is involved in the contract manufacturing business. It serves wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, and individual provider offices, as well as disease control and prevention centers. The company has collaboration agreements with Bristol-Myers Squibb Company; Astellas Pharma US, Inc.; Myovant Sciences Ltd.; Akcea Therapeutics, Inc; Merck KGaA; Valneva SE; BioNTech SE; and Arvinas, Inc. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.
Full PFE Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.